PMID- 20450986 OWN - NLM STAT- MEDLINE DCOM- 20101229 LR - 20151119 IS - 1879-3649 (Electronic) IS - 1537-1891 (Linking) VI - 53 IP - 3-4 DP - 2010 Sep-Oct TI - Adult rats are more sensitive to the vascular effects induced by hyperhomocysteinemia than young rats. PG - 99-106 LID - 10.1016/j.vph.2010.04.006 [doi] AB - We aimed to investigate the vascular effects of hyperhomocysteinemia (HHcy) on carotid arteries from young and adult rats. With this purpose young and adult rats received a solution of DL-homocysteine-thiolactone (1 g/kg body weight/day) in the drinking water for 7, 14 and 28 days. Increase on plasma homocysteine occurred in young and adult rats treated with DL-homocysteine-thiolactone in all periods. Vascular reactivity experiments using standard muscle bath procedures showed that HHcy enhanced the contractile response of endothelium-intact, carotid rings to phenylephrine in both young and adult rats. However, in young rats, the increased phenylephrine-induced contraction was observed after hyperhomocysteinemia for 14 and 28 days, whereas in adult rats this response was already apparent after 7 day treatment. HHcy impaired acetylcholine-induced relaxation in arteries from adult but not young rats. The contraction induced by phenylephrine in carotid arteries in the presence of Y-27632 was reversed to control values in arteries from young but not adult rats with hyperhomocysteinemia. HHcy did not alter the contraction induced by CaCl(2) in carotid arteries from young rats, but enhanced CaCl(2)-induced contraction in the arteries from adult rats. HHcy increased the basal levels of superoxide anion in arteries from both groups. Finally, HHcy decreased the basal levels of nitrite in arteries from adult but not young rats. The major new finding of the present work is that arteries from young rats are more resistant to vascular changes evoked by HHcy than arteries from adult rats. Also, we verified that the enhanced vascular response to phenylephrine observed in carotid arteries of DL-homocysteine thiolactone-treated rats is mediated by different mechanisms in young and adult rats. CI - Copyright 2010. Published by Elsevier Inc. FAU - de Andrade, Claudia Roberta AU - de Andrade CR AD - Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo (USP), Ribeirao Preto, SP, Brazil. FAU - de Campos, Glenda Andrea Destro AU - de Campos GA FAU - Tirapelli, Carlos Renato AU - Tirapelli CR FAU - Laurindo, Francisco R M AU - Laurindo FR FAU - Haddad, Renato AU - Haddad R FAU - Eberlin, Marcos N AU - Eberlin MN FAU - de Oliveira, Ana Maria AU - de Oliveira AM LA - eng PT - Comparative Study PT - Journal Article DEP - 20100505 PL - United States TA - Vascul Pharmacol JT - Vascular pharmacology JID - 101130615 RN - 0 (Amides) RN - 0 (Cyclooxygenase Inhibitors) RN - 0 (Pyridines) RN - 0 (Vasoconstrictor Agents) RN - 0LVT1QZ0BA (Homocysteine) RN - 11062-77-4 (Superoxides) RN - 138381-45-0 (Y 27632) RN - 1WS297W6MV (Phenylephrine) RN - 31C4KY9ESH (Nitric Oxide) RN - D5H88XF24X (homocysteine thiolactone) RN - EC 2.7.11.1 (rho-Associated Kinases) RN - M4I0D6VV5M (Calcium Chloride) RN - N9YNS0M02X (Acetylcholine) RN - XXE1CET956 (Indomethacin) SB - IM MH - Acetylcholine/pharmacology MH - Age Factors MH - Amides/pharmacology MH - Animals MH - Calcium Chloride/pharmacology MH - Carotid Arteries/*drug effects/physiopathology MH - Cyclooxygenase Inhibitors/pharmacology MH - Endothelium, Vascular/drug effects/physiopathology MH - Homocysteine/*analogs & derivatives/blood/pharmacology MH - Hyperhomocysteinemia/*physiopathology MH - Indomethacin/pharmacology MH - Male MH - Muscle Contraction/drug effects MH - Muscle, Smooth, Vascular/drug effects/physiopathology MH - Nitric Oxide/physiology MH - Phenylephrine/pharmacology MH - Pyridines/pharmacology MH - Rats MH - Rats, Wistar MH - Superoxides/metabolism MH - Vasoconstrictor Agents/pharmacology MH - Vasodilation/*drug effects MH - rho-Associated Kinases/physiology EDAT- 2010/05/11 06:00 MHDA- 2010/12/30 06:00 CRDT- 2010/05/11 06:00 PHST- 2009/10/22 00:00 [received] PHST- 2010/04/19 00:00 [revised] PHST- 2010/04/22 00:00 [accepted] PHST- 2010/05/11 06:00 [entrez] PHST- 2010/05/11 06:00 [pubmed] PHST- 2010/12/30 06:00 [medline] AID - S1537-1891(10)00087-X [pii] AID - 10.1016/j.vph.2010.04.006 [doi] PST - ppublish SO - Vascul Pharmacol. 2010 Sep-Oct;53(3-4):99-106. doi: 10.1016/j.vph.2010.04.006. Epub 2010 May 5.